Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
What Are Biologics and Small Molecules for Ulcerative Colitis?
Advanced therapies—biologics and small molecules—offer targeted treatment for moderate to severe ulcerative colitis. Biologics are injectable antibodies that block specific immune proteins, while small molecules are oral agents that inhibit intracellular inflammatory pathways. Clinical experience shows remission often begins within six to eight weeks, and long‑term use can reduce flare frequency and colon‑cancer risk. Dr. Suresh Pola emphasizes adherence to maintain efficacy and avoid antibody formation.
Transforming the U.S. Department of Veterans Affairs: A Conversation with Deputy Secretary Dr. Paul Lawrence
In this hour-long interview, Deputy Secretary Dr. Paul Lawrence outlines his role as the VA’s chief operating officer and shares the department’s strategic vision to deliver world‑class health care, benefits, and memorial services to veterans. He highlights three urgent priorities:...
Emyria Launches Empax Global Partnership Platform Targeting International Drug Sponsors
Emyria (ASX:EMD) has launched the Empax Global Partnership Platform, giving international drug sponsors and CROs direct access to its clinical delivery infrastructure for complex psychedelic‑assisted therapies. The service creates a dual‑revenue model that blends existing reimbursed treatment programs with high‑margin,...
Assisted Suicide Is The Logical Outcome Of Government-Controlled Medical Care
The article argues that Canada’s Medical Assistance in Dying (MAID) program, now responsible for over 100,000 deaths in ten years, is a logical outcome of government‑controlled health care. It highlights recent expansions to include non‑terminal illnesses, mental health conditions, and...
Trump Cuts Crucial Health Research Funding, Fueling Crisis
This piece in the WaPo summarizes what I've been say. The feds under Trump are choking off research dollars -- particularly for women's health, cancer and mental health. Young researchers are particularly hard hit, steering scientists into other work. It's...
Blue Zones’ Dan Burden Marks 80th with Call for Outdoor Adventure to Boost Longevity
Dan Burden, Blue Zones Director of Inspiration & Innovation, celebrated his 80th birthday by telling Blue Zones how outdoor adventure fuels longevity and purpose. His interview highlights the need for community‑driven outdoor programs to keep aging adults engaged and healthy.
Calling The Iconic 867-5309 Phone Number Now Goes To A Cancer Helpline
The Cancer Support Community (CSC) has rebranded the famous 867‑5309 number as its national helpline, partnering with health‑marketing agency Klick Health and Tommy Heath of Tommy Tutone. Launched on March 17, 2026, the CSC‑867‑5309 line offers free cancer‑support, information, and personalized guidance. Within...
ChronicCareIQ Names Venkata Reddy Gogulamudi as CTO to Accelerate AI in Chronic Care
ChronicCareIQ announced Venkata Reddy Gogulamudi as its new chief technology officer. The veteran health‑tech executive will steer technology strategy, AI integration and product architecture as the company expands its chronic disease management platform nationwide.
Guyana Deploys One‑Minute AI Imaging Service at New Optique Eye Hospital
President Irfaan Ali announced the rollout of an artificial‑intelligence tool that delivers radiology reads in under a minute at the newly opened Optique Eye Hospital. The system, already live at two public hospitals, promises to slash diagnostic delays across Guyana’s...
FDA Seeks More Cardiovascular Data on Eli Lilly’s Orforglipron After Safety Concerns
The U.S. FDA has asked Eli Lilly to provide further cardiovascular safety data on its newly approved oral GLP‑1 weight‑loss drug Orforglipron, after the agency’s approval letter flagged “unexpected serious risks.” Lilly says patient safety remains its top priority as it...
Bipartisan Bill Aims to Ban Vertical Integration of Insurers, PBMs and Providers
Senators Elizabeth Warren and Josh Hawley introduced the Break Up Big Medicine Act, a bipartisan proposal that would bar parent companies from simultaneously owning insurers, pharmacy‑benefit managers, providers, or wholesalers. The measure seeks to dismantle the vertical integration that lawmakers...
Hospitals Gain Profit by Accepting All Patients
Appreciate it. A couple reasons why we disagree. Most don’t know if their commercial insured business is profitable by carrier. But that’s a topic for another day. Most hospital assets/caregivers (surgeons and some others that get...
Alembic Pharma Secures US FDA Nod for Generic Methotrexate Injection, Boosting US Generics Portfolio
Alembic Pharmaceuticals announced US FDA approval for its generic methotrexate injection USP on April 16, 2026. The clearance covers 50 mg/2 mL multi‑dose and 1 g/40 mL single‑dose vials, bringing the Indian drugmaker’s total US ANDA approvals to 236. The move strengthens Alembic’s foothold...
Gene‑Therapy Pioneers Win $3 Million Breakthrough Prize for Vision and Sickle‑Cell Treatments
The Breakthrough Prize Foundation awarded a $3 million Life Sciences prize to three University of Pennsylvania scientists and two collaborators for pioneering gene‑therapy treatments that restore sight in Leber congenital amaurosis and target sickle‑cell disease. The honor spotlights Luxturna’s market entry...
Representation in Medicine Can Be Life‑Saving
This Black Doctor is amazing. The importance of having doctors that understand us is so important. It’s is truly a matter of life and death.
Boosting Mitochondrial NAD+/NADH Extends Life, Eases Alzheimer’s
Extension of Lifespan and Amelioration of Alzheimer's Disease Phenotypes by Genetic Manipulation of Mitochondrial NAD+/NADH Ratio https://t.co/m8K1Tm9sIR https://t.co/SU85G9FsgW
The Medications Quietly Harming Your Brain (And the Ones Getting Unfairly Blamed)
A psychiatrist highlights that over‑the‑counter sleep aids like diphenhydramine and chronic use of prescription sedatives pose measurable long‑term cognitive risks, often exceeding the danger of untreated insomnia. He contrasts these with antidepressants, which he argues are generally safe for brain...
Zombie Immune Cells Linked to Fatty Liver, Inflammation, Aging
UCLA scientists identify zombie immune cells as a driver of fatty liver disease, inflammation and aging https://t.co/28Ql5er4kb https://t.co/IoAD5I6AJr
FDA Approves Breakthrough Therapy for Critically Ill Children
FDA says ‘yes’ to transformative therapy for sick children — and more media coverage of UCLA https://t.co/N6AJsRwCyX
Eli Lilly to Spend $6.3 B on Centessa Buy, with up to $1.5 B in Milestone Payouts
Eli Lilly agreed to acquire UK‑based Centessa Pharmaceuticals for an upfront $6.3 billion, plus a contingent value right that could add $1.5 billion if the lead sleep‑wake disorder drug meets regulatory milestones. The deal, priced at a 40% premium, follows Lilly’s cash‑rich...
MAHA Pushes Revival of Discredited Snake‑oil Cures
In my @BakerInstitute article I explain how MAHA seeks to restore the fake medical cures and snake oils, which the Flexner Report thankfully shut down in 1910, homeopathy, ecclectism, botanicals, so they could sell their nostrums and make money, they...
AI Boosts Radiologist Demand, Not Replacement
AI didn’t replace radiologists. It made them MORE needed. That’s Jevons paradox. #Kaihan #Outthinker #AI #FutureOfWork #Innovation https://t.co/SYDLpp6GmV
NTU Unveils AI‑Powered Biochip That Detects Disease Biomarkers in 20 Minutes
Scientists at Singapore’s Nanyang Technological University have built an AI‑driven nanophotonic biochip that can identify disease‑related microRNA biomarkers in roughly 20 minutes. The prototype pairs a camera and mobile app for real‑time analysis, aiming to cut diagnostic turnaround times dramatically.
Axtria Acquires Conexus Solutions to Add AI‑Powered CRM for Life‑Sciences Companies
Axtria announced the acquisition of Conexus Solutions, a Veeva and Salesforce‑focused CRM transformation partner, to embed end‑to‑end CRM capabilities into its AI‑first data analytics suite for life‑sciences firms. While the financial terms were not disclosed, the deal is positioned as...
Combined NMN and CD38 Inhibitor Rejuvenates Aging Muscles
Double-Pronged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration https://t.co/bnkkn0xblj Scheme 1: A novel synergistic drug combination (N + A) consisting of an NAD+ precursor (NMN) and an NAD+ consumption (CD38) inhibitor (API) promotes musculoskeletal regeneration in aging.
Indiana Sets Three‑Month Medicaid Work Rule as Federal One‑Month Standard Takes Effect
The federal Medicaid work‑requirement rule, signed into law under the One Big Beautiful Bill Act, now obliges new adult applicants to show at least one month of employment, schooling or volunteering. Indiana has gone further, enacting a three‑month requirement that...
FDA Grants Breakthrough Therapy Designation to Plixorafenib for Rare CNS Tumors
The U.S. FDA has granted Breakthrough Therapy Designation to plixorafenib, an investigational BRAF inhibitor for adults with rare, high‑grade gliomas harboring the BRAF V600E mutation. Early‑stage data showed a 67% overall response rate, positioning the drug as a potential game‑changer...
Chinese Spouse Can Work at NHIA with Restrictions
A Chinese spouse who passed Taiwan's national civil exam can be hired by the National Health Insurance Administration, but the appointment excludes any role involving national security or classified information. The decision follows consultation with the Mainland Affairs Council and...
Economic Burden of Falls for 190 Countries and Territories From 2020 to 2050 Based on Health-Augmented Macroeconomic Modelling
A new health‑augmented macroeconomic model estimates that falls will cost the global economy about INT $3.939 trillion (≈ $3.9 trillion USD) between 2020 and 2050, representing roughly 0.088% of cumulative world GDP. The United States, China and Germany account for the largest absolute losses....
A Cluster-Randomized Trial of Labelled Cash Transfers for Uptake of Care for Chronic Conditions Among Middle-Aged and Older Adults in...
A cluster‑randomized trial in Burkina Faso tested whether small, labelled cash transfers would boost health‑service uptake among adults aged 45 and older with chronic conditions. The study enrolled 2,400 participants across 30 villages, offering a $10 (≈ USD 10) incentive conditional on...
Labor Is Manufacturing an NDIS Crisis to Justify Cuts - the Savings Will Be Spent on War
The Albanese Labor government has embarked on a coordinated campaign to shrink the National Disability Insurance Scheme (NDIS), stripping $14.4 billion in the 2024 budget and projecting $19 billion in savings over four years. A review commissioned in 2022 and a RedBridge‑led...
HSAs’ Triple Tax Benefit Can Be Outweighed by HDHP Costs
Why Health Savings Accounts (HSAs) Aren’t Always Worth The ‘Triple Tax Savings’ Advantage: https://t.co/6zrY3GAuEd HSAs require individuals to be covered by a High Deductible Health Plan (HDHP), which has tradeoffs compared to traditional health insurance plans. While HDHPs are often expected to...
Health, Resilience and Prosperity: Why Immunization Matters
European health leaders are urging a paradigm shift: immunisation should be treated as a strategic investment in resilience, not merely a childhood disease‑prevention tool. The EU now links vaccines to cancer prevention, cardiovascular risk reduction, antimicrobial‑resistance mitigation, and brain‑health protection....
The Potential Threats of Anthropic Mythos to the NHS
Anthropic’s Mythos model, a frontier large‑language model capable of autonomous vulnerability discovery and exploitation, marks a watershed in AI‑driven cyber offense. Independent testing shows Mythos achieving an 83.1% success rate on the CyberGym benchmark and a 72% end‑to‑end exploit rate,...
HIV Treatment Reduces Accelerated Biological Aging by Nearly Four Years, Landmark Study Shows
A landmark study presented at ESCMID Global 2026 shows that antiretroviral therapy (ART) reduces the accelerated biological aging seen in people with HIV (PWH) by an average of 3.7 years after roughly 1.5 years of treatment. Researchers used a plasma...
Improving Oral Care More than Halves Hospital-Acquired Pneumonia Risk, Major Trial Finds
The Hospital Acquired Pneumonia Prevention (HAPPEN) study, a stepped‑wedge cluster RCT across three Australian hospitals and 8,870 patients, demonstrated that a structured oral‑care program reduced non‑ventilator‑associated hospital‑acquired pneumonia (NV‑HAP) incidence by roughly 60%, from 1.00 to 0.41 cases per 100...
Antibiotic Resistance Genes Found in Newborns Within Hours of Birth, Study Shows
A new ESCMID Global 2026 study examined meconium from 105 NICU infants and found antibiotic resistance genes (ARGs) within hours of birth. The most prevalent genes were oqxA (98%) and qnrS (96%), with beta‑lactamase genes such as blaCTX‑M present in...
/file/dailymaverick/wp-content/uploads/2025/06/Daryl-Swanepoel.jpg)
Beyond Binaries — Why NHI Success Depends on Design, Not Ideology
South Africa’s National Health Insurance (NHI) debate has become a binary clash over universal coverage, but the real issue is how to design a sustainable system. The article argues that design, not ideology, determines success, citing China’s layered insurance model...
Vaccine Refusal Endangers Infants; Protect Babies From Hospitalization
This is happening because of vaccine refusal. Please protect your babies and other peoples babies. This virus frequently leads to hospitalization and can lead t
Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development
Simulations Plus Inc (NASDAQ:SLP) announced on March 26 that three major pharmaceutical firms have joined its AI‑enabled modeling collaboration programs, embedding the company’s AI agents directly into their drug‑development workflows. The firm emphasized a fully integrated AI deployment rather than...
What’s Schrodinger Inc (SDGR) Working Out with Anthropic?
Schrödinger Inc. announced at the KeyBanc Healthcare Forum that it will move 75% of its software contracts to hosted, cloud‑based models within three years, responding to growing customer demand. The company is also collaborating with Anthropic and other AI firms...
Butterfly Network Inc (BFLY): Top Medical AI Stock to Buy
Butterfly Network announced FDA clearance for its AI‑powered handheld ultrasound that estimates gestational age in under two minutes. The AI model was trained on millions of diverse ultrasound images, aiming to improve prenatal care in emergency and rural settings. In...
Favorable Zio Results Brighten iRhythm Holdings, Inc (IRTC)’s Prospects
iRhythm Holdings presented new clinical data at the ACC 2026 Scientific Sessions showing its Zio patch identified actionable arrhythmias in nearly half of patients with chronic kidney disease and markedly higher atrial fibrillation detection in severely obese individuals. The company...
Here’s What Piper Sandler Thinks About Boston Scientific Corp (BSX) Now
Piper Sandler reaffirmed its Overweight rating on Boston Scientific (BSX) after the Champion‑AF trial showed the Watchman left‑atrial appendage closure device met all safety and efficacy endpoints. The firm projects Watchman sales to grow 20% annually, contributing roughly 200 basis...
How Will OpenClaw Impact Healthcare Technology in 2026?
OpenClaw, an open‑source agentic orchestration framework acquired by OpenAI, is reshaping healthcare technology in 2026 by linking advanced LLMs with legacy hospital IT. Its four‑module architecture—Gateway, Agent Core, Skills Layer, and Heartbeat Engine—enables autonomous tasks such as EMR navigation, real‑time...
India's Liver Disease Claims Double, Costs Surge for Young Adults
Care Health Insurance's latest analysis, released on World Liver Day 2026, shows liver disease insurance claims in India have doubled over three years and treatment costs have nearly doubled. The surge is driven by younger patients and residents of Tier‑2...
Get Free Dietitian Care with Blue Cross Texas
Dietitians & quality nutrition care shouldn’t be a ✨luxury✨... You might be able to see a dietitian through your insurance… for $0. (Yes, actually.) Especially if you have Blue Cross Blue Shield TX. Most of my patients see me weekly. That would *normally* cost...
Pain Meds Denied, Horse Tranquilizers and Weed Allowed
We’ve removed access to pain medicine for millions of people who need it but everyone on horse tranquilizers and weed is perfectly fine
Leaked Images Show Monkeys Forced Into Weight‑Loss Drug Tests in UK Labs
A former laboratory technician leaked graphic footage of long‑tailed macaques being restrained and fed experimental anti‑obesity drugs via oral gavage in two UK facilities. The images, obtained by The Mail on Sunday, have ignited calls for faster phasing out of...
Unexpected Insight Among 11 Lessons From AACR26
11 things I learned at #AACR26 Industry Partnering event – number 7 may well surprise you: https://t.co/T0ePbaIU1K https://t.co/CMh15HfnnG